Clinical Trial Update: A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a potassium normalization regimen including sodium zirconium cyclosilicate in patients with hyperkalemia; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Sodium Zirconium Cyclosilicate (sodium zirconium cyclosilate)

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalemia | Phase 2 | Status: COMPLETED | Results posted: 2020-01-28